Author

Alessandro Magli

Observed names: A Magli, A. Magli, ALESSANDRO MAGLI, Alessandro Magli1, Magli, Alessandro

Observed institutions: University of Insubria, University of Udine, University of Milan, Ospedale di Circolo e Fondazione Macchi, Agostino Gemelli University Polyclinic, Ospedale Santa Chiara, Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia, Ospedale Santa Maria della Misericordia di Udine, IRCCS Ospedale San Raffaele, Ospedale Policlinico San Martino, Ospedale Sant'Anna, Fondazione IRCCS Istituto Nazionale dei Tumori, Aziende Socio Sanitarie Territoriale dei Sette Laghi, Azienda ULSS n. 1 Dolomiti, Azienda sanitaria universitaria Friuli Centrale, Azienda sanitaria universitaria Giuliano Isontina, European Institute of Oncology, University of Brescia

ORCID: 0000-0002-7004-1938

Observed ORCID: 0000-0002-7004-1938

OpenAlex ID: A5011697206

Relationships between DVHs and late rectal bleeding after radiotherapy for prostate cancer: analysis of a large group of patients pooled from three institutions

2002 · Claudio Fiorino, Cesare Cozzarini, et al. · Radiotherapy and Oncology · 186

Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study

2017 · Luca Triggiani, Filippo Alongi, et al. · British Journal of Cancer · 149

PDF

A multicenter study of the prognosis and treatment of adult brain ependymal tumors

2004 · Michele Reni, Alba Ariela Brandes, et al. · Cancer · 115

Predictors for Rectal and Intestinal Acute Toxicities During Prostate Cancer High-Dose 3D-CRT: Results of a Prospective Multicenter Study

2007 · Vittorio Vavassori, Claudio Fiorino, et al. · International Journal of Radiation Oncology*Biology*Physics · 100

Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study

2019 · Luca Triggiani, Rosario Mazzola, et al. · World Journal of Urology · 96

Development of a Set of Nomograms to Predict Acute Lower Gastrointestinal Toxicity for Prostate Cancer 3D-CRT

2008 · Riccardo Valdagni, Tiziana Rancati, et al. · International Journal of Radiation Oncology*Biology*Physics · 72

COVID-19 outbreak and cancer radiotherapy disruption in Italy: Survey endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO)

2020 · Barbara Alicja Jereczek-Fossa, Matteo Pepa, et al. · Radiotherapy and Oncology · 53

PDF

European Association of Urology Biochemical Recurrence Risk Classification as a Decision Tool for Salvage Radiotherapy—A Multicenter Study

2023 · Felix Preisser, Raisa S. Abrams-Pompe, et al. · European Urology · 48

Consensus statements on ablative radiotherapy for oligometastatic prostate cancer: A position paper of Italian Association of Radiotherapy and Clinical Oncology (AIRO)

2019 · Rolando M. D’Angelillo, Giulio Francolini, et al. · Critical Reviews in Oncology/Hematology · 42

Daily Sodium Butyrate Enema for the Prevention of Radiation Proctitis in Prostate Cancer Patients Undergoing Radical Radiation Therapy: Results of a Multicenter Randomized Placebo-Controlled Dose-Finding Phase 2 Study

2014 · Angelo Maggio, Alessandro Magli, et al. · International Journal of Radiation Oncology*Biology*Physics · 42

Adjuvant PEFG (Cisplatin, Epirubicin, 5-Fluorouracil, Gemcitabine) or Gemcitabine Followed by Chemoradiation in Pancreatic Cancer: A Randomized Phase II Trial

2012 · Michele Reni, Gianpaolo Balzano, et al. · Annals of Surgical Oncology · 36

Laryngeal long-term morbidity after supraglottic laryngectomy and postoperative radiation therapy

2000 · Giuseppe Spriano, Paolo Antognoni, et al. · American Journal of Otolaryngology · 31

Hypofractionated simultaneous integrated boost (IMRT-SIB) with pelvic nodal irradiation and concurrent androgen deprivation therapy for high-risk prostate cancer: results of a prospective phase II trial

2018 · Alessandro Magli, Eugenia Moretti, et al. · Prostate Cancer and Prostatic Diseases · 25

PDF

Toxicity at 1 Year After Stereotactic Body Radiation Therapy in 3 Fractions for Localized Prostate Cancer

2021 · Alessandro Magli, Alessia Farneti, et al. · International Journal of Radiation Oncology*Biology*Physics · 24

Erectile dysfunction after prostate three-dimensional conformal radiation therapy

2012 · A. Magli, M. Giangreco, et al. · Strahlentherapie und Onkologie · 24

A Systematic Review on Intensity Modulated Radiation Therapy for Mediastinal Hodgkin’s Lymphoma

2021 · Michela Buglione, Andrea Emanuele Guerini, et al. · Critical Reviews in Oncology/Hematology · 18

Practice patterns for prostate cancer in nine central and northern Italy radiation oncology centers: a survey including 1759 patients treated during two decades (1980–1998)

2002 · Stefano Maria Magrini, Filippo Bertoni, et al. · International Journal of Radiation Oncology*Biology*Physics · 17

Analysis of patients with locally advanced rectal cancer given neoadjuvant radiochemotherapy with or without RT dose intensification: A multicenter retrospective study – ATLANTIS part I

2024 · Luca Nicosia, Marco Lorenzo Bonù, et al. · Radiotherapy and Oncology · 15

Why we should take care of the competing risk bias in survival analysis: A phase II trial on the toxicity profile of radiotherapy for prostate cancer

2019 · Annarita Tullio, Alessandro Magli, et al. · Reports of Practical Oncology & Radiotherapy · 14

PDF

Predictors of 2-Year Incidence of Patient-Reported Urinary Incontinence After Post-prostatectomy Radiotherapy: Evidence of Dose and Fractionation Effects

2020 · Andrea Bresolin, Elisabetta Garibaldi, et al. · Frontiers in Oncology · 13

PDF

Pelvic bone marrow dose-volume predictors of late lymphopenia following pelvic lymph node radiation therapy for prostate cancer

2024 · Maddalena Pavarini, Lisa Alborghetti, et al. · Radiotherapy and Oncology · 12

Upfront metastasis-directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance

2021 · Luca Triggiani, Rosario Mazzola, et al. · Medical Oncology · 12

Toxicity profile and Patient-Reported outcomes following salvage Stereotactic Ablative Radiation Therapy to the prostate Bed: The POPART multicentric prospective study

2023 · Federica Ferrario, Ciro Franzese, et al. · Clinical and Translational Radiation Oncology · 11

PDF

Treatment of muscle-invasive bladder cancer in patients without comorbidities and fit for surgery: Trimodality therapy vs radical cystectomy. Development of GRADE (Grades of Recommendation, Assessment, Development and Evaluation) recommendation by the Italian Association of Radiotherapy and Clinical Oncology (AIRO)

2021 · Giulio Francolini, Simona Borghesi, et al. · Critical Reviews in Oncology/Hematology · 11

Brentuximab vedotin in combination with extended field radiotherapy as salvage treatment for primary refractory H odgkin lymphoma

2014 · Massimo Dozzo, Francesco Zaja, et al. · American Journal of Hematology · 11

PDF

Works count: 145

Citation count: 1,310

H-index: 17

I10-index: 28